Key facts
- everskin’s last known valuation is $5.2M (Jan 2025).
- It has raised $770K; the latest was Angel (individual) ($770K) in Jan 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for everskin
- ·The full record, as it builds
Funding rounds
No funding rounds for everskin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About everskin
Provider of skin analysis treatment intended to enhance understanding of skin conditions. The company's platform utilizes proprietary dermatological research to offer insights into skin health, identify optimal treatments, and monitor progress over time, enabling individuals to make informed decisions regarding their skincare and improve overall skin wellness effectively.
- Sector
- Healthcare
- HQ
- Zürich, Switzerland
- Founded
- 2024
- Employees
- 8
- Website
- everskin.ch/de
- Ownership
- Privately Held (backing)
everskin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in everskin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on everskin in its N-PORT filings yet. We sweep new filings monthly.